The popular heartburn drug ranitidine, the generic form of Zantac, was linked to cancer in September, prompting some voluntary recalls of the drug and an investigation by the FDA. A lab in California has also been working to get to the bottom of its potential dangers. First on “CBS This Morning,” Dr. Jon LaPook has a look inside that lab.
